+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Veterinary Drug Market 2020-2026

  • PDF Icon


  • June 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129752
Global Veterinary Drug Market Size, Share & Trends Analysis Report, By Animal (Livestock, Companion, Other), By Type (Anti-Parasitic, Anti-inflammatory, Anti-infective, Others), By Route of Administration (Oral, Injection, Topical, Other) and Forecast, 2020-2026
The veterinary drug market is expected to witness a CAGR of around 5.5% during the forecast period 2020-2026. Increasing the adoption of pet animals, the growing possibility of zoonotic diseases and growth in meat and dairy consumption are the key factors for the growth of the market globally. Besides, growth in new drug launch by the companies, online access to the drugs, improvement in the health infrastructure for animals is some of the other factors driving the growth of the market all across the globe.

The global veterinary drug market is divided on the basis of animal, type, and route of administration. By animal, the market is further divided into livestock, companion, other. During the forecast period, companion animals are expected to have a major market share owing to better facilities reach to them provided by their owners. On the basis of type, the market is further divided into anti-parasitic, anti-inflammatory, anti-infective, and others. By route of administration, the market is divided into oral, injection, and topical. Oral route holds a significant market share in the market
The veterinary drug market is also studied by geography and is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). During the forecast period, North America is expected to hold a major market share. Moreover, a lucrative growth is expected in Asia-Pacific due to rising pet ownership, and increasing veterinary healthcare infrastructure in emerging economies.

The veterinary drug market is a fragmented market however a large market is occupied by a few companies. Some of the key players in the market include Zoetis, Inc., Bayer AG, BOEHRINGER Ingelheim International GmbH, Ceva Santé Animale, Merck & Co., Inc., Elanco Animal Health Inc., Vetoquinol S.A., and Virbac S.A. These companies are adopting growth strategies including mergers and acquisitions, product launches, and partnerships & collaborations to gain a competitive edge in the market.

Research Methodology

The market study of the global veterinary drug market is incorporated by extensive primary and secondary research. Secondary research has been conducted to breakdown the market in various segments; derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts to amplify the added validity of the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:
  • Global Veterinary Drug Market Research and Analysis, By Animal
  • Global Veterinary Drug Market Research and Analysis, By Type
  • Global Veterinary Drug Market Research and Analysis, By Route of Administration

The Report covers:
  • Comprehensive research methodology of the Global Veterinary Drug Market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Veterinary drug Market.
  • Insights about market determinants which are stimulating the Global Veterinary Drug Market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdowns
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Zoetis, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Merck & Co., Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. Boehringer Ingelheim International GmbH Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Bayer AG Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. Elanco Animal Health Inc. Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. Global Veterinary Drug Market by Animal
5.1.1. Livestock Poultry Swine Cattle Aquatic Others (Sheep)
5.1.2. Companion
5.1.3. Other
5.2. Global Veterinary Drug Market by Type
5.2.1. Anti-Parasitic
5.2.2. Anti-inflammatory
5.2.3. Anti-infective
5.2.4. Others
5.3. Global Veterinary Drug Market by Route of Administration
5.3.1. Oral
5.3.2. Topical
5.3.3. Injection
5.3.4. Other
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Akorn Animal Health, Inc.
7.2. Bayer AG
7.3. Bimeda Holdings PLC
7.4. Biogenesis Bago A.S.
7.5. BOEHRINGER Ingelheim International GmbH
7.6. Ceva Santé Animale
7.7. Dechra Pharmaceuticals PLC
7.8. Elanco Animal Health Inc.
7.9. Hipra S.A.
7.10. Huvepharma EOOD
7.11. Hygieia Biological Laboratories
7.12. Intervet International B.V
7.13. Merck & Co., Inc.
7.14. Neogen Corp.
7.15. Pharmgate LLC
7.16. Phibro Animal Health Corp.
7.17. Vetoquinol S.A.
7.18. Virbac S.A.
7.19. Zoetis, Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Akorn Animal Health, Inc.
  • Bayer AG
  • Bimeda Holdings PLC
  • Biogenesis Bago A.S.
  • BOEHRINGER Ingelheim International GmbH
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc.
  • Hipra S.A.
  • Huvepharma EOOD
  • Hygieia Biological Laboratories
  • Intervet International B.V
  • Merck & Co., Inc.
  • Neogen Corp.
  • Pharmgate LLC
  • Phibro Animal Health Corp.
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis, Inc.